AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
Maximize Market Research said in a press release that the global AI in clinical trials market was valued at USD 2 billion in 2025 and could reach USD 7.32 billion by 2034. The forecast represents a compound annual growth rate of 15.5% from 2026 to 2034.
AI applications covered by the report include patient recruitment, cohort selection, trial design, clinical data analysis, safety monitoring, drug discovery, personalized medicine, patient monitoring, and treatment optimization. The report examines machine learning, natural language processing, and deep learning across Phase I, Phase II, and Phase III trials.
North America currently leads the market, while adoption is also growing in Europe and the Asia Pacific region. The report identifies data privacy, regulatory compliance, data quality, transparency, reliability, and a shortage of specialized AI expertise as constraints on adoption.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
DC Market Insights forecasts server market to reach $1.31 trillion by 2035
AstraZeneca and Oracle Partner on AI for Clinical Trials
Global Drone Market Forecast to Reach $21.41 Billion by 2034
Atlas Bio raises $12.5 million for virtual drug trials
Omdia: AI software revenue to pass $200 billion in 2026 as generative AI grows 139%
Daily AI Brief: the AI news that matters, in your inbox.